Activation of vascular endothelium can be problem with LVADs

Young, James B.
June 2008
Cardiology Today;Jun2008, Vol. 11 Issue 6, p14
The article focuses on the study presented by Ranjit John, MD, assistant professor, division of cardiovascular surgery at the University of Minnesota regarding the effect of vascular endothelium activation in patients with a left ventricular assist device (LVAD). It mentions that persistent vascular endothelium activation may be a trigger to create a sustained prothrombotic environment in patients with LVADs. Results of the study in patients with an LVAD on the day of implantation and at the postoperative days seven, 90 and 180 are discussed.


Related Articles

  • Product Pipeline.  // Cardiovascular Devices & Drugs;Jun2009, Vol. 15 Issue 6, p24 

    The article reports that the SynCardia temporary CardioWest Total Artificial Heart from SynCardia posted a bridge-to-transplant rate of 72 percent at six months in its study. According to the Tucson, Arizona-based company, the artificial heart has been designed to serve as a replacement to dying...

  • First-in-man study begins for arterial stents.  // Medical Device Daily;8/12/2008, Vol. 12 Issue 174, p8 

    The article reports on the statement of Flexible Stenting Solution that physician Andrew Holden at Auckland City Hospital in New Zealand has successfully implanted several of its third-generation arterial stents for the treatment of peripheral vascular lesions involving the superficial femoral...

  • Tryton launches Side Branch stent for bifurcated lesions.  // Medical Device Daily;9/29/2008, Vol. 12 Issue 207, p1 

    The article reports on the launch of the Side Branch Stent System from cardiovascular stent maker Tryton Medical. The device is designed to treat atherosclerotic lesions at the site of a bifurcation. The Netherlands will be the first country where the device will be launched with additional...

  • Current Status of the MicroMed DeBakey Noon Ventricular Assist Device. Noon, George P.; Loebe, Matthias // Texas Heart Institute Journal;2010, Vol. 37 Issue 6, p652 

    The article describes improvements made to the DeBakey axial-flow ventricular assist device (VAD) for patients in need of surgical implants. The results of surgical procedures using the implant in Germany in 1998 and in the U.S. in 2002 led to the development of the device HeartAssist5â„¢....

  • Reevaluation of Temporary Transvenous Cardiac Pacemaker Usage During Carotid Angioplasty and Stenting. Bush, Ruth L.; Lin, Peter H.; Bianco, Charles C.; Hurt, Julian E.; Lawhorn, Thomas I.; Lumsden, Alan B. // Vascular & Endovascular Surgery;May/Jun2004, Vol. 38 Issue 3, p229 

    Although many current series document the safety of carotid angioplasty and stenting procedures (CAS), several acknowledge clinically significant hemodynamic disturbances in 25-71% of patients. We report herein the safety and efficacy of prophylactic percutaneous temporary transvenous cardiac...

  • CorNova wins CE mark for Valecor stent.  // Cardiovascular Devices & Drugs;Aug2009, Vol. 15 Issue 8, p15 

    The article reports that CorNova's Valecor Platinum Coronary Stent System is Conformité Européenne (CE) approved. The cobalt-chromium bare-metal stent is equipped with an implantation technology called Nanofusion which provides protection for the lumen and artery wall from less...

  • Shelhigh to cease distribution, will meet FDA production standards.  // Cardiovascular Device Update;Jul2007, Vol. 13 Issue 7, p17 

    The article reports on the decision of Shelhigh to stop distributing its implantable medical devices used in heart surgery and other procedures until it brings its production processes in line with the standards of the U.S. Food and Drug Administration (FDA). Shelhigh contended that its decision...

  • Termination of Implantable Pacemaker Therapy: Experience in Five Patients. Iskos, Demosthenes; Lurie, Keith G. // Annals of Internal Medicine;05/15/97, Vol. 126 Issue 10, p787 

    Presents a study on the termination of implantable pacemaker therapy among five cardiac patients. Analysis and feasibility of terminating cardiac pacing; Parameters of patient safety after terminating pacemaker therapy; Factors to consider in terminating pacemaker therapy.

  • The Implications of Human Stem Cell Differentiation to Endothelial Cell Via Fluid Shear Stress in Cardiovascular Regenerative Medicine: A Review. Tan, Aaron; Sumpio, Bauer E.; Lee, Samuel; Seifalian, Alexander M. // Current Pharmaceutical Design;11/30/2010, Vol. 16 Issue 34, p3848 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics